Original Research
Published on 23 Jul 2020
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2020.01796
- 22,716 views
- 136 citations
